New American Therapeutics

In the fall of 2010, Deerfield facilitated the creation of New American Therapeutics, a specialty pharmaceutical company run by several former senior executives from Roche and Sanofi-Aventis. Our investment was used to purchase Denavir®, a marketed topical cream for the treatment of cold sores.

Press releases

Deerfield Divests topical herpes drug Denavir to Renaissance Pharmaceuticals
October 2010

Renaissance Pharma Acquires Cold Sore Treatment Denavir®
August 2012